Adaptimmune Therapeutics plc (ADAP) Slipped -7.61% or -0.74 To Price $9.04 On Friday


Adaptimmune Therapeutics plc (ADAP) slipped -7.61% or -0.74 to $9.04. It is approximately 520195 shares traded, which is 126.28% compare to the average total volume 411950. The market cap of ADAP is $851.53 million. The year to date change is 30.28%. The 52 week price range is from $4.82 to $14.62. Price of ADAP have changed -1.51% during last week. It have changed -16.96% over last month, -24.92% over last 3 months, 11.89% over last 6 months and 85.07% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ADAP is 11.80. It is 30.53% above current price. The 200-day Moving Averages for ADAP is 9.85. It is 8.96% above current price. The 52-week High is 14.62. It is 61.73% from the current price. The 52-week Low is 4.82. It is -46.68% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ADAP is 5.96 on 2018-07-13. Short % to float is 3.69%. There are some statistics of ADAP. It is has market cap $851.53 million. The share outstanding is 94.14 million. The average volume is 411950. The revenue is 30.71M. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ADAP is -32.12%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ADAP is -25.03%.


Tags:

Share this post